| abstract |
The present invention relates to a condensed pyrrolecarboxamide of formula (I) In the formula, R 1 to R 9, X, m and n are as defined in the claims. Compounds of formula (I) are inhibitors of acid-sensitive potassium channel TASK-1 and are associated with TASK-1 channel mediated diseases, such as arrhythmias, in particular atrial arrhythmias such as atrial fibrillation and atrial fibrillation, and respiratory disorders, especially for example sleep apnea. It is also suitable for treating sleep related respiratory disorders. |